Design and rationale of Effisayil 1, a Phase II, multicenter, randomized, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis with an acute flare

被引：0

作者：

Choon, Siew Eng ^{[1
]}

Lebwohl, Mark G. ^{[2
]}

Marrakchi, Slaheddine ^{[3
]}

Burden, A. David ^{[4
]}

Tsai, Tsen-Fang ^{[5
,6
]}

Morita, Akimichi ^{[7
]}

Navarini, Alexander A. ^{[8
]}

Deng, Hongjie ^{[9
]}

Thoma, Christian ^{[10
]}

Bachelez, Herve ^{[11
]}

机构：

[1] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Clin Sch Johor Bahru, Selangor Darul Ehsan, Malaysia

[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[3] Hedi Chaker Univ Hosp, Dept Dermatol, Sfax, Tunisia

[4] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Scotland

[5] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan

[6] Natl Taiwan Univ, Coll Med, Taipei, Taiwan

[7] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Japan

[8] Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland

[9] Boehringer Ingelheim China Investment Co Ltd, Shanghai, Peoples R China

[10] Boehringer Ingelheim Int Gmbh, Biberach, Germany

[11] Univ Paris, Inst Imagine, UMR INSERM U1163, Paris, France

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

26590

引用

页码：AB109 / AB109

页数：1

共 50 条

[1] Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare
Choon, Siew Eng
Lebwohl, Mark G.
Marrakchi, Slaheddine
Burden, A. David
Tsai, Tsen-Fang
Morita, Akimichi
Navarini, Alexander A.
Zheng, Min
Xu, Jinhua
Turki, Hamida
Rajeswari, Sushmita
Deng, Hongjie
Tetzlaff, Kay
Thoma, Christian
Bachelez, Herve
BMJ OPEN, 2021, 11 (03):
[2] Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis
Akimichi Morita
Siew Eng Choon
Hervé Bachelez
Milan J. Anadkat
Slaheddine Marrakchi
Min Zheng
Tsen-Fang Tsai
Hamida Turki
Harry Hua
Sushmita Rajeswari
Christian Thoma
A. David Burden
Dermatology and Therapy, 2023, 13 : 347 - 359
[3] Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis
Morita, Akimichi
Choon, Siew Eng
Bachelez, Herve
Anadkat, Milan J.
Marrakchi, Slaheddine
Zheng, Min
Tsai, Tsen-Fang
Turki, Hamida
Hua, Harry
Rajeswari, Sushmita
Thoma, Christian
Burden, A. David
DERMATOLOGY AND THERAPY, 2023, 13 (01) : 347 - 359
[4] Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil™ 1 study
Morita, Akimichi
Tsai, Tsen-Fang
Yee, Evelyn Yap Wen
Okubo, Yukari
Imafuku, Shinichi
Zheng, Min
Li, Ling
Quaresma, Manuel
Thoma, Christian
Choon, Siew Eng
JOURNAL OF DERMATOLOGY, 2023, 50 (02): : 183 - 194
[5] Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study
Elewski, Boni E.
Lebwohl, Mark G.
Anadkat, Milan J.
Barker, Jonathan
Ghoreschi, Kamran
Imafuku, Shinichi
Mrowietz, Ulrich
Li, Ling
Quaresma, Manuel
Thoma, Christian
Bachelez, Herve
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (01) : 36 - 44
[6] A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
Cui, Chuanliang
Mao, Lili
Chi, Zhihong
Si, Lu
Sheng, Xinan
Kong, Yan
Li, Siming
Lian, Bin
Gu, Kangsheng
Tao, Min
Song, Xin
Lin, Tongyu
Ren, Xiubao
Qin, Shukui
Guo, Jun
MOLECULAR THERAPY, 2013, 21 (07) : 1456 - 1463
[7] Efficacy of Spesolimab for rapid Control of Disease Flares in Patients with Generalized Pustular Psoriasis (GPP): Results of the placebo-controlled Effisayil-1 Study
Bachelez, Herve
Barker, Jonathan
Ghoreschi, Kamran
Elewski, Boni E.
Xu, Jinhua
Hu, Na
Quaresma, Manuel
Thoma, Christian
Lebwohl, Mark
Mockenhaupt, Maja
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 17 - 18
[8] Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA)
Pascual-Figal, Domingo
Villota, Julio Nunez
Perez-Martinez, Maria Teresa
Gonzalez-Juanatey, Jose Ramon
Taibo-Urquia, Mikel
Iborra, Pau Llacer
Gonzalez-Martin, Javier
Villar, Sandra
Soler, Meritxel
Mirabet, Sonia
Aimo, Alberto
Riquelme-Perez, Alejandro
Sanchez, Manuel Anguita
Martinez-Selles, Manuel
Sanchez, Pedro L.
Ibanez, Borja
Bayes-Genis, Antoni
EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (09) : 1999 - 2007
[9] Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial
Tsen-Fang Tsai
Min Zheng
Yangfeng Ding
Zhiqi Song
Quanzhong Liu
Ying Chen
Hanzhao Hu
Jinhua Xu
Dermatology and Therapy, 2023, 13 : 3097 - 3110
[10] A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis
Bissonnette, R
Papp, K
Poulin, Y
Lauzon, G
Aspeslet, L
Huizinga, R
Mayo, P
Foster, RT
Yatscoff, RW
Maksymowych, WP
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : 472 - 478

← 1 2 3 4 5 →